S&P 500   4,267.52
DOW   33,665.02
QQQ   348.82
Stock market today: Asian shares slip following technology selloff on Wall Street
66,000% upside on tiny biotech? (Ad)
Tesla: How and Why It Gets To $300
Don't Overlook Hidden Gem Kinsale As Rallies To New Highs
Bank Collapse Causes Gold Prices to Soar (Ad)
AI-powered IoT Automation is Driving Samsara To New Highs
What is a Growth Stock Mutual Fund?
Bank Collapse Causes Gold Prices to Soar (Ad)
Persistent inflation, higher interest rates will weigh on global economy, OECD predicts
Sprinklr Gets Targets Raised By Analysts, Here's Why
S&P 500   4,267.52
DOW   33,665.02
QQQ   348.82
Stock market today: Asian shares slip following technology selloff on Wall Street
66,000% upside on tiny biotech? (Ad)
Tesla: How and Why It Gets To $300
Don't Overlook Hidden Gem Kinsale As Rallies To New Highs
Bank Collapse Causes Gold Prices to Soar (Ad)
AI-powered IoT Automation is Driving Samsara To New Highs
What is a Growth Stock Mutual Fund?
Bank Collapse Causes Gold Prices to Soar (Ad)
Persistent inflation, higher interest rates will weigh on global economy, OECD predicts
Sprinklr Gets Targets Raised By Analysts, Here's Why
S&P 500   4,267.52
DOW   33,665.02
QQQ   348.82
Stock market today: Asian shares slip following technology selloff on Wall Street
66,000% upside on tiny biotech? (Ad)
Tesla: How and Why It Gets To $300
Don't Overlook Hidden Gem Kinsale As Rallies To New Highs
Bank Collapse Causes Gold Prices to Soar (Ad)
AI-powered IoT Automation is Driving Samsara To New Highs
What is a Growth Stock Mutual Fund?
Bank Collapse Causes Gold Prices to Soar (Ad)
Persistent inflation, higher interest rates will weigh on global economy, OECD predicts
Sprinklr Gets Targets Raised By Analysts, Here's Why
S&P 500   4,267.52
DOW   33,665.02
QQQ   348.82
Stock market today: Asian shares slip following technology selloff on Wall Street
66,000% upside on tiny biotech? (Ad)
Tesla: How and Why It Gets To $300
Don't Overlook Hidden Gem Kinsale As Rallies To New Highs
Bank Collapse Causes Gold Prices to Soar (Ad)
AI-powered IoT Automation is Driving Samsara To New Highs
What is a Growth Stock Mutual Fund?
Bank Collapse Causes Gold Prices to Soar (Ad)
Persistent inflation, higher interest rates will weigh on global economy, OECD predicts
Sprinklr Gets Targets Raised By Analysts, Here's Why
NASDAQ:BWAY

BrainsWay (BWAY) Stock Forecast, Price & News

$2.23
+0.13 (+6.19%)
(As of 06/7/2023 ET)
Compare
Today's Range
$2.10
$2.28
50-Day Range
$1.46
$2.10
52-Week Range
$1.38
$7.00
Volume
232,058 shs
Average Volume
75,633 shs
Market Capitalization
$36.97 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$6.67

BrainsWay MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
199.0% Upside
$6.67 Price Target
Short Interest
Healthy
0.04% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
-0.25mentions of BrainsWay in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.25) to ($0.16) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.18 out of 5 stars

Medical Sector

327th out of 981 stocks

Surgical & Medical Instruments Industry

33rd out of 97 stocks


BWAY stock logo

About BrainsWay (NASDAQ:BWAY) Stock

Brainsway Ltd. engages in the development and sale of non-invasive neurostimulation treatments using the proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the treatment of major depressive disorder (MDD) and obsessive-compulsive disorder (OCD). The Deep TMS uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. The company was founded by Avner Hagai, Yiftach Roth, Abraham Zangen, and David Zacut on November 7, 2006 and is headquartered in Jerusalem, Israel.

Receive BWAY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BrainsWay and its competitors with MarketBeat's FREE daily newsletter.

BWAY Stock News Headlines

The Latest Analyst Ratings for BrainsWay
H.C. Wainwright Keeps Their Buy Rating on Brainsway (BWAY)
This Company Is Solving A Multi-Billion Dollar Problem!
This Little Known NASDAQ Stock is Solving a Multi-Billion Dollar Problem!
BrainsWay Appoints Ido Marom To Succeed Scott Areglado As CFO
BrainsWay appoints CFO
BrainsWay Announces Appointment of Ido Marom as CFO
The Stock That's Brining Lithium Back To America!
The American Energy Crisis Is Very Real And This Stock Is Solving That Problem On U.S Soil
BrainsWay - Aiming For Revenue Growth And Profitability
BrainsWay: Q1 Earnings Insights
Earnings Outlook For BrainsWay
BrainsWay (NASDAQ:BWAY) Price Target Cut to $12.00
See More Headlines

BWAY Price History

BWAY Company Calendar

Last Earnings
3/15/2023
Today
6/07/2023
Next Earnings (Estimated)
8/09/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:BWAY
Fax
N/A
Employees
100
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$6.67
High Stock Price Forecast
$12.00
Low Stock Price Forecast
$3.00
Forecasted Upside/Downside
+195.0%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Net Income
$-13,350,000.00
Pretax Margin
-52.21%

Debt

Sales & Book Value

Annual Sales
$27.18 million
Book Value
$2.75 per share

Miscellaneous

Free Float
13,430,000
Market Cap
$37.47 million
Optionable
Not Optionable
Beta
0.94

Key Executives

  • Hadar Levy
    Chief Executive Officer
  • Richard Scott Areglado
    Chief Financial Officer & Senior Vice President
  • Yiftach Roth
    Chief Scientific Officer
  • Moria Ben Soussan Ankri
    Vice President-Research & Development
  • Aron Tendler
    Chief Medical Officer













BWAY Stock - Frequently Asked Questions

Should I buy or sell BrainsWay stock right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for BrainsWay in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" BWAY shares.
View BWAY analyst ratings
or view top-rated stocks.

What is BrainsWay's stock price forecast for 2023?

3 analysts have issued twelve-month price targets for BrainsWay's stock. Their BWAY share price forecasts range from $3.00 to $12.00. On average, they predict the company's stock price to reach $6.67 in the next twelve months. This suggests a possible upside of 195.0% from the stock's current price.
View analysts price targets for BWAY
or view top-rated stocks among Wall Street analysts.

How have BWAY shares performed in 2023?

BrainsWay's stock was trading at $2.47 at the start of the year. Since then, BWAY stock has decreased by 8.5% and is now trading at $2.26.
View the best growth stocks for 2023 here
.

When is BrainsWay's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 9th 2023.
View our BWAY earnings forecast
.

How were BrainsWay's earnings last quarter?

BrainsWay Ltd. (NASDAQ:BWAY) posted its earnings results on Wednesday, March, 15th. The company reported ($0.12) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.12). The business earned $6.03 million during the quarter, compared to analysts' expectations of $6.10 million. BrainsWay had a negative trailing twelve-month return on equity of 28.89% and a negative net margin of 53.37%.

What other stocks do shareholders of BrainsWay own?

Based on aggregate information from My MarketBeat watchlists, some companies that other BrainsWay investors own include AbbVie (ABBV), Advanced Micro Devices (AMD), Enterprise Products Partners (EPD), Pfizer (PFE), Neuronetics (STIM), Boingo Wireless (WIFI), Ampio Pharmaceuticals (AMPE), Eastman Chemical (EMN), Enbridge (ENB) and Energy Transfer (ET).

When did BrainsWay IPO?

(BWAY) raised $30 million in an initial public offering on Wednesday, April 17th 2019. The company issued 2,500,000 shares at a price of $11.94 per share. Cantor acted as the underwriter for the IPO.

What is BrainsWay's stock symbol?

BrainsWay trades on the NASDAQ under the ticker symbol "BWAY."

Who are BrainsWay's major shareholders?

BrainsWay's stock is owned by many different institutional and retail investors. Top institutional investors include Wasatch Advisors LP (6.00%), Renaissance Technologies LLC (0.19%) and Good Life Advisors LLC (0.11%).

How do I buy shares of BrainsWay?

Shares of BWAY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is BrainsWay's stock price today?

One share of BWAY stock can currently be purchased for approximately $2.26.

How much money does BrainsWay make?

BrainsWay (NASDAQ:BWAY) has a market capitalization of $37.47 million and generates $27.18 million in revenue each year. The company earns $-13,350,000.00 in net income (profit) each year or ($0.41) on an earnings per share basis.

How can I contact BrainsWay?

BrainsWay's mailing address is 19 HARTUM STREET BYNET BUILDING 3RD FL Har HaHotzvim, Jerusalem L3, 9777518. The official website for the company is www.brainsway.com. The company can be reached via phone at (722) 582-4030 or via email at hadarl@brainsway.com.

This page (NASDAQ:BWAY) was last updated on 6/8/2023 by MarketBeat.com Staff

My Account -